Agilent Says $2.2B Dako Buy Will Boost Life Sciences Biz

Law360, New York (May 17, 2012, 1:41 PM EDT) -- Agilent Technologies Inc. will pick up Danish cancer diagnostics company Dako in a $2.2 billion debt-free deal with its current owner, Swedish private equity firm EQT, in a plan to augment Santa Clara, Calif.-based Agilent's life sciences business, the firms said Thursday.

The cash acquisition will be the largest ever for Agilent, which expects to close the deal within 60 days.

Agilent eyed Dako — which supplies tools mainly to pathology laboratories for use in cancer diagnoses — to pad its revenues and provide a stronger...
To view the full article, register now.